Trial
NCT05105061
Intramuscular Ketamine for Suicidal Ideation
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Icahn School of Medicine at Mount Sinai
Collaborators
—
Condition
Suicidal Ideation
Intervention
Ketamine (Ketalar)
Why stopped
PI leaving institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-04-05